FLT3 and acute myeloid leukemia: Univariate analyses of aGVHD and cGVHD revealed that there were no significant differences in age, HSCT type, AML subtype, cytogenetic risk, HCT-CI, conditioning regimens, response to induction therapy, MRD, or Flt3 status between the two groups, as shown in Table 4.